An Analytical Method Built for Irinotecan and Its Active Metabolite SN-38 in Human Plasma Using HPLC-FLD

SHAO Teng-fei,ZHENG Yuan-ting,XU Jia-lin,CAI Wei-min

DOI: https://doi.org/10.13286/j.cnki.chinhosppharmacyj.2012.01.020

2012-01-01

Abstract:OBJECTIVE To develop and validate a method for simultaneous determination of irinotecan(CPT-11) and its metabolite SN-38 in human plasma by HPLC-FLD. METHODS Chromatographic separation was performed on a Luna 5u CN 100A column(4.6 mm×150 mm,5 μm),using acetonitrile: ammonium acetate(50 mmol·L-1,pH=4) as mobile phase.The detection wavelength of CPT-11 was Ex/Em=368 nm/432 nm,and the detection wavelength of SN-38 was Ex/Em=368 nm/535 nm. RESULTS The retention time of CPT-11 and SN-38 was(9.3±0.3)min and(4.8±0.3)min,respectively.No interfering peaks were observed at the retention time of both targets and interna standards.The assay was linear at the range 46.9-6 000.0 nmol·L-1 for CPT-11(r=0.998) and 2.0-250.0 nmol· L-1 for SN-38(r=0.998).Both the inter-and intra-batch precisions were less than 20% at the low concentration and less than 15% at the middle and high concentrations.The inter-and intra-accuracies were all between 85% and 115%.The spiked plasma samples were stable at-20 ℃ in a long-term stability test.After three freeze-thaw cycles of the spiked samples,the changes in levels of SN-38 and CPT-11 were both within 15%.The changes in levels of SN-38 and CPT-11 in 24 h after extraction were not obvious. CONCLUSION HPLC-FLD method for detection of concentrations of irinotecan(CPT-11) and its active metabolites SN-38 in human plasma is simple,accurate and sensitive.